
Kimberly-Clark (KMB) Stock Forecast & Price Target
Kimberly-Clark (KMB) Analyst Ratings
Bulls say
Kimberly-Clark is a leading manufacturer in the tissue and hygiene market, generating over half of its sales from North America and a significant portion from Europe, Asia, and Latin America. The company's robust innovation pipeline anticipated for 2026 is expected to enhance its product offerings and competitive advantage, particularly as it integrates Kenvue's consumer health portfolio into its operations. Despite some challenges in the North American diaper category due to increased competition, Kimberly-Clark's commitment to innovation and product development positions it favorably for sustained growth and market leadership.
Bears say
Kimberly-Clark is facing a significant projected decline in its organic sales for the third quarter of 2025, with estimates indicating a downturn of -4.0%, a stark reversal from previous expectations of growth. Additionally, the company's measured retail sales in the U.S. have also declined by -2.7% year-to-date for the third quarter of 2025, highlighting deteriorating sales performance. Furthermore, the forecasted earnings per share (EPS) for fiscal year 2025 has been revised downward from $7.60 to $7.41, and the 2026 EPS estimate has also decreased from $8.00 to $7.85, reflecting worsening financial outlooks.
This aggregate rating is based on analysts' research of Kimberly-Clark and is not a guaranteed prediction by Public.com or investment advice.
Kimberly-Clark (KMB) Analyst Forecast & Price Prediction
Start investing in Kimberly-Clark (KMB)
Order type
Buy in
Order amount
Est. shares
0 shares